HRP20110813T1 - Idebenon za liječenje respiratornih bolesti u mišićnoj distrofiji - Google Patents

Idebenon za liječenje respiratornih bolesti u mišićnoj distrofiji Download PDF

Info

Publication number
HRP20110813T1
HRP20110813T1 HR20110813T HRP20110813T HRP20110813T1 HR P20110813 T1 HRP20110813 T1 HR P20110813T1 HR 20110813 T HR20110813 T HR 20110813T HR P20110813 T HRP20110813 T HR P20110813T HR P20110813 T1 HRP20110813 T1 HR P20110813T1
Authority
HR
Croatia
Prior art keywords
ibedenone
use according
muscular dystrophy
administered
treatment
Prior art date
Application number
HR20110813T
Other languages
English (en)
Croatian (hr)
Inventor
Buyse Gunnar
Meier Thomas
Original Assignee
Santhera Pharmaceuticals (Schweiz) Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39691216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110813(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Santhera Pharmaceuticals (Schweiz) Ag filed Critical Santhera Pharmaceuticals (Schweiz) Ag
Publication of HRP20110813T1 publication Critical patent/HRP20110813T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HR20110813T 2008-04-09 2011-11-02 Idebenon za liječenje respiratornih bolesti u mišićnoj distrofiji HRP20110813T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08007069A EP2108366B1 (fr) 2008-04-09 2008-04-09 Idébenone pour le traitement des maladies respiratoires dans la dystrophie musculaire

Publications (1)

Publication Number Publication Date
HRP20110813T1 true HRP20110813T1 (hr) 2011-11-30

Family

ID=39691216

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110813T HRP20110813T1 (hr) 2008-04-09 2011-11-02 Idebenon za liječenje respiratornih bolesti u mišićnoj distrofiji

Country Status (17)

Country Link
US (1) US20110092469A1 (fr)
EP (1) EP2108366B1 (fr)
JP (1) JP2011516513A (fr)
AT (1) ATE529104T1 (fr)
AU (1) AU2009235681B2 (fr)
CA (1) CA2719440C (fr)
CY (1) CY1112313T1 (fr)
DK (1) DK2108366T3 (fr)
ES (1) ES2370607T3 (fr)
HR (1) HRP20110813T1 (fr)
MX (1) MX2010011099A (fr)
NZ (1) NZ588181A (fr)
PL (1) PL2108366T3 (fr)
PT (1) PT2108366E (fr)
SI (1) SI2108366T1 (fr)
WO (1) WO2009124693A1 (fr)
ZA (1) ZA201006905B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
EP2620141A1 (fr) * 2012-01-25 2013-07-31 Santhera Pharmaceuticals (Schweiz) AG Système d'administration de médicament à couche mince pour l'administration transmucosale d'un dérivé de benzoquinone
WO2014035356A1 (fr) * 2012-08-31 2014-03-06 Mahmut Bilgic Préparations de comprimés comportant un agent actif de dérivé quinonique
CN103040779B (zh) * 2013-01-01 2015-04-15 刘炜 用于神经系统疾病的口服固体药物组合物
US20140329762A1 (en) * 2013-03-15 2014-11-06 Sarepta Therapeutics, Inc. Compositions for treating muscular dystrophy
CN109364050B (zh) * 2018-10-19 2021-02-02 大连医科大学 艾地苯醌在制备治疗肺动脉高压药物中的应用
US20220175800A1 (en) * 2019-04-12 2022-06-09 Ptc Therapeutics Inc. Dispersible tablet composition
WO2022258629A1 (fr) 2021-06-07 2022-12-15 Katholieke Universiteit Leuven Idébénone dans le traitement de l'épilepsie pharmacorésistante

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51128932A (en) 1975-04-30 1976-11-10 Takeda Chem Ind Ltd Organic compounds
AU8562998A (en) 1997-08-12 1999-03-01 Takeda Chemical Industries Ltd. Idebenone-containing preparation for percutaneous administration
JPH11116470A (ja) 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
CA2272971C (fr) 1998-10-29 2008-01-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Derives de la quinone pour le traitement ou la prevention de maladies associees a une surcharge en fer
DE602006014514D1 (fr) * 2005-03-21 2010-07-08 Santhera Pharmaceuticals Ch
EP1891946A1 (fr) 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Administration transmuqueuse de la 2,3-diméthoxy-5-méthyl-6-(10-hydroxydecyl)-1,4-benzoquinone

Also Published As

Publication number Publication date
ZA201006905B (en) 2011-06-29
EP2108366B1 (fr) 2011-10-19
CA2719440C (fr) 2013-07-16
US20110092469A1 (en) 2011-04-21
SI2108366T1 (sl) 2012-01-31
PL2108366T3 (pl) 2012-03-30
CY1112313T1 (el) 2015-12-09
EP2108366A1 (fr) 2009-10-14
AU2009235681B2 (en) 2012-04-05
ATE529104T1 (de) 2011-11-15
ES2370607T3 (es) 2011-12-20
MX2010011099A (es) 2010-11-01
JP2011516513A (ja) 2011-05-26
CA2719440A1 (fr) 2009-10-15
WO2009124693A1 (fr) 2009-10-15
NZ588181A (en) 2011-11-25
PT2108366E (pt) 2011-11-10
AU2009235681A1 (en) 2009-10-15
DK2108366T3 (da) 2012-01-30

Similar Documents

Publication Publication Date Title
HRP20110813T1 (hr) Idebenon za liječenje respiratornih bolesti u mišićnoj distrofiji
US20250268866A1 (en) Nasal Compositions and Method of Use Thereof
Loguercio et al. A 36-month evaluation of self-etch and etch-and-rinse adhesives in noncarious cervical lesions
EP3273948B1 (fr) Capsules molles remplies de liquide
Femiano et al. Pilot study on recurrent aphthous stomatitis (RAS): a randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy
JP2009536147A5 (fr)
AR045076A1 (es) Composicion de pelicula que se disuelve oralmente, pelicula multicomponente que se disuelve oralmente, uso de la composicion de pelicula y de la pelicula que se disuelve oralmente para preparar un medicamento, forma de dosificacion oral y procedimiento para preparar la composicion de pelicula que se
KR20090091321A (ko) 나노입자 제형, 이의 제조방법 및 이의 용도
JP2004514739A5 (fr)
CA2660577A1 (fr) Administration par voie transmuqueuse de 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
Fourie et al. Oral mucosal ulceration-a clinician’s guide to diagnosis and treatment
MX2019008482A (es) Tratamiento medico que comprende administracion enteral de edaravona.
BR0014979A (pt) Composição hormonal e sua utilização
JP2008534523A5 (fr)
CA2602290A1 (fr) Derive de quinone 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4- benzoquinone pour le traitement de dystrophies musculaires
CN104968317B (zh) 含无定形磷酸钙的局部用泛醇口腔补充组合物
Kisby Glass-Hybrid Restorations in Pediatric Patients.
JP2013234173A (ja) 口腔用半固形剤
JP2018526420A5 (fr)
CN105030818A (zh) 一种i型聚维酮碘含漱液及其配制工艺
Ferreira et al. Orodispersible films for compounding pharmacies
VUČIĆEVIĆ BORAS et al. Gingival necrosis caused by an Ill-Fitting Denture
JP2010189301A (ja) 新型インフルエンザ感染症に対する医薬組成物およびその利用
Bethell et al. Present status of treatment of pernicious anemia: ninth announcement of USP Anti-Anemia Preparations Advisory Board
Rafi Case study of a patient who experienced an allergic reaction after using a substance for dental impressions. iraetc med. bull; 2 (4) 50-52. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license